DepYmed to Meet with Investors at the LSX World Congress USA in Boston on September 13-14, 2023
FARMINGDALE, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare diseases and oncology that target the protein tyrosine …